Plaintiffs Fight Privilege Claim In Neurontin Case
Direct purchaser plaintiffs accusing Pfizer Inc. and a subsidiary of blocking generic competition for the epilepsy drug Neurontin by filing baseless patent litigation want a federal judge to look for evidence...To view the full article, register now.
Already a subscriber? Click here to view full article